Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).

被引：0
|
作者：
Wakelee, Heather A.
Padda, Sukhmani Kaur
Burns, Matthew
Spittler, Aaron John
Riess, Jonathan
San Pedro-Salcedo, Melanie
Ramchandran, Kavitha
Gubens, Matthew A.
Neal, Joel W.
Loehrer, Patrick J.
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[2] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[3] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[4] UC San Francisco, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7580
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
    Swiecicki, Paul L.
    Yilmaz, Emrullah
    Rosenberg, Ari Joseph
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Zhao, Yongyun
    Mihm, Michael
    Kaplan, Jason
    Gorla, Seema
    Geiger, Jessica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [22] A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines
    Vici, Patrizia
    Di Lauro, Luigi
    Sergi, Domenico
    Foggi, Paolo
    Viola, Giuditta
    Mottolese, Marcella
    Giotta, Francesco
    Fattoruso, Silvia I. S.
    Corsetti, Serena
    Giannarelli, Diana
    Botti, Claudio
    Lopez, Massimo
    ONCOLOGY, 2008, 75 (3-4) : 175 - 181
  • [23] Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC)
    Santoro, A.
    Citterio, G.
    Pressiani, T.
    Gregorc, V.
    Rimassa, L.
    De Braud, F. G.
    Rossoni, G.
    Cappio, F. Caligaris
    Lambiase, A.
    Bordignon, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 395 - 395
  • [24] A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Tomizawa, Yoshio
    Yanagitani, Noriko
    Shimizu, Kimihiro
    Imai, Hisao
    Utsugi, Mitsuyoshi
    Iwasaki, Yasuki
    Iijima, Hironobu
    Tsurumaki, Hiroaki
    Yoshii, Akihiro
    Fueki, Naoto
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Saito, Ryusei
    Mori, Masatomo
    LUNG CANCER, 2010, 69 (01) : 99 - 104
  • [25] Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
    Okuma, Yusuke
    Goto, Yasushi
    Ohyanagi, Fumiyoshi
    Sunami, Kuniko
    Nakahara, Yoshiro
    Kitazono, Satoru
    Kudo, Keita
    Tambo, Yuichi
    Kanda, Shintaro
    Yanagitani, Noriko
    Horiike, Atsushi
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Nishio, Makoto
    Ohe, Yuichiro
    Hosomi, Yukio
    CANCER MEDICINE, 2020, 9 (20): : 7418 - 7427
  • [26] Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma
    Ohyanagi, F.
    Okuma, Y.
    Goto, Y.
    Sunami, K.
    Nakahara, Y.
    Kitazono, S.
    Tambo, Y.
    Yanagitani, N.
    Kanda, S.
    Horiike, A.
    Horinouchi, H.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Nishio, M.
    Ohe, Y.
    Hosomi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1868 - S1868
  • [27] Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
    Okuma, Y.
    Goto, Y.
    Ohyanagi, F.
    Sunami, K.
    Nakahara, Y.
    Kitazono, S.
    Tambo, Y.
    Yanagitani, N.
    Kanda, S.
    Horinouchi, H.
    Horiike, A.
    Fujiwara, Y.
    Nokihara, H.
    Yamamoto, N.
    Nishio, M.
    Ohe, Y.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [28] Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial
    Robert S. Witte
    Judith Manola
    Patrick A. Burch
    Timothy Kuzel
    Eric L. Weinshel
    Patrick J. Loehrer
    Investigational New Drugs, 1998, 16 : 191 - 195
  • [29] Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial
    Witte, RS
    Manola, J
    Burch, PA
    Kuzel, T
    Weinshel, EL
    Loehrer, PJ
    INVESTIGATIONAL NEW DRUGS, 1998, 16 (02) : 191 - 195
  • [30] Phase II Study of Sunitinib in Patients with Thymic Carcinoma Previously Treated with Platinum-Based Chemotherapy (KOSMIC Trial)
    Kim, S. H.
    Kim, Y. J.
    Ock, C.
    Kim, M.
    Keam, B.
    Kim, T. M.
    Kim, D.
    Heo, D. S.
    Lee, J. S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S346 - S347
12345